Ambulatory cardiac monitors are small, movable electrocardiograph machines that can record the heart’s rhythm. The features in such monitors vary based on the length of recording time and the ability to send the recordings over the phone. Most professional experts use ambulatory cardiac monitors to assess heartbeat rate over time, correlate symptoms with the heartbeat, diagnose abnormal heart rhythms, and analyze other symptoms a heart can have. These devices help monitor the heart with increased detection time and with more precise results as compared to conventional heart monitors. This is likely to boost the global ambulatory cardiac monitoring devices market during the forecast period.
In simpler terms, ambulatory cardiac monitoring devices are used to assist doctors to diagnose irregular cardiac arrhythmias that occur only sporadically and unpredictably. Such arrhythmias often exhibit sudden symptoms, but usually are not present by the time the patient gets to a doctor. For this reason, many symptom-producing cardiac arrhythmias are challenging or unlikely to diagnose with conventional ECGs. Ambulatory cardiac monitoring devices have proven useful to monitor and record the heartbeats for longer spans to capture a brief, irregular, but potentially vital arrhythmia. The growing number of heart-related cases across the world owing to factors such as increasing obesity, diabetes mellitus, smoking, high cholesterol, high blood pressure, and sedentary lifestyles, are expected to be major factors driving the global ambulatory cardiac monitoring devices market.
COVID-19 has posed various kinds of challenges for doctors whose cardiac patients are at-risk and hesitant to schedule a visit. People with cardiac issues are concerned about coronavirus, but in their caution, they can die from an unmonitored, untreated cardiac condition. Besides, the number of deaths from cardiac diseases is more than that of COVID-19 patients. However, at a time when cardiac monitoring is more critically important than ever, patients may have greater hesitation to visit a hospital. Moreover, people in rural areas face more challenges of having to travel to the doctor, as they might not have at least one cardiologist nearby. Interns and practitioners are being trained to use cardiac monitoring devices in case of emergencies. This has propelled the ambulatory cardiac monitoring devices market. However, stringent regulations for travel, manufacturing, supply chain, and trade to limit the virus have impacted the production and distribution of such devices.
There has been a notable decrease in admissions for cardiac arrests and failure, owing to the threat coronavirus poses on heart patients. Moreover, there is accumulating evidence to suggest COVD-19 has vital and even long-term cardiac effects, which may lead to a series of heart failure patients leading to a new crisis. Thus, the demand for the use of ambulatory cardiac monitoring devices is hindered during this time. However, with the growing number of vaccinations in various nations and innovation in medicines and drugs, the global ambulatory cardiac monitoring devices market is expected to surge post-COVID-19.
The most advanced and minimally invasive surgery utilization to improve patients' heart activity and intensify the outcomes of various cardiac procedures is one of the key factors propelling the growth of the ambulatory cardiac monitoring devices market. Moreover, the rising demand for advanced cardiac devices, such as Holter monitors, event monitors, implantable loop recorders, mobile cardiac telemetry helping the future ambulatory cardiac monitoring devices market growth. Furthermore, rising government and people investment in healthcare and favorable reimbursement policies are among the major factors expanding the ambulatory cardiac monitoring devices market.
Analysts’ Viewpoint
The global medical data suggests that one out of 10 people suffers from heart-related issues, including coronary heart disease, angina, high and low blood pressure, heart attack, arrhythmia, and valve blockage. Thus, ambulatory cardiac monitoring devices have become necessary to track and monitor the heart to avoid fatal outcomes of such diseases. Cardiac monitoring is also crucial in the administration of heart attacks, the value of cardiac output, and for monitoring of sepsis cases. Ambulatory cardiac monitoring devices are also used to detect, eliminate, and restrict mycoplasma infection in cell culture, making them fit for use in research institutions and organizations. The growing concerns of heart patients and an increasing number of such patients are driving the ambulatory cardiac monitoring devices market.
Ambulatory Cardiac Monitoring Devices Market – Segmentation
| Type |
|
| Region |
|
Ambulatory cardiac monitoring devices market to cross valuation of US$29 Bn by 2031
Ambulatory cardiac monitoring devices market is driven by rise in demand for prolonged ECG monitoring & self-care management and increase in burden of cardiovascular diseases
North America accounted for a major share of the global ambulatory cardiac monitoring devices market
The ECG devices segment captured the largest market share in 2020 and the trend is likely to continue during the forecast period
Key players operating in the global ambulatory cardiac monitoring devices market are Abbott, Boston Scientific Corporation, GE Healthcare, Hill-Rom Holdings, Koninklijke Philips N.V., Medtronic, Nihon Kohden Corporation, Asahi Kasei Medical Co., Ltd.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Ambulatory Cardiac Monitoring Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Prevalence of Heart Failure
5.2. Brand Analysis
5.3. Patient Pathway for Ambulatory Cardiac Monitoring
5.4. Value Chain Analysis
5.5. Pricing Analysis
5.6. Reimbursement Scenario
5.7. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. ECG Devices
6.3.1.1. Resting ECG Devices
6.3.1.2. Stress ECG Devices
6.3.2. Holter Monitors
6.3.3. Event Monitors
6.3.4. Implantable Loop Recorders
6.3.5. Mobile Cardiac Telemetry
6.4. Market Attractiveness Analysis, by Type
7. Global Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Market Value Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness Analysis, by Country/Region
8. North America Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast, by Type, 2017–2031
8.2.1. ECG Devices
8.2.1.1. Resting ECG Devices
8.2.1.2. Stress ECG Devices
8.2.2. Holter Monitors
8.2.3. Event Monitors
8.2.4. Implantable Loop Recorders
8.2.5. Mobile Cardiac Telemetry
8.3. Market Value Forecast, by Country, 2017–2031
8.3.1. U.S.
8.3.2. Canada
8.4. Market Attractiveness Analysis
8.4.1. By Type
8.4.2. By Country
9. Europe Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Type, 2017–2031
9.2.1. ECG Devices
9.2.1.1. Resting ECG Devices
9.2.1.2. Stress ECG Devices
9.2.2. Holter Monitors
9.2.3. Event Monitors
9.2.4. Implantable Loop Recorders
9.2.5. Mobile Cardiac Telemetry
9.3. Market Value Forecast, by Country/Sub-region, 2017–2031
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe
9.4. Market Attractiveness Analysis
9.4.1. By Type
9.4.2. By Country/Sub-region
10. Asia Pacific Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017–2031
10.2.1. ECG Devices
10.2.1.1. Resting ECG Devices
10.2.1.2. Stress ECG Devices
10.2.2. Holter Monitors
10.2.3. Event Monitors
10.2.4. Implantable Loop Recorders
10.2.5. Mobile Cardiac Telemetry
10.3. Market Value Forecast, by Country/Sub-region, 2017–2031
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Market Attractiveness Analysis
10.4.1. By Type
10.4.2. By Country/Sub-region
11. Latin America Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2031
11.2.1. ECG Devices
11.2.1.1. Resting ECG Devices
11.2.1.2. Stress ECG Devices
11.2.2. Holter Monitors
11.2.3. Event Monitors
11.2.4. Implantable Loop Recorders
11.2.5. Mobile Cardiac Telemetry
11.3. Market Value Forecast, by Country/Sub-region, 2017–2031
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Attractiveness Analysis
11.4.1. By Type
11.4.2. By Country/Sub-region
12. Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2031
12.2.1. ECG Devices
12.2.1.1. Resting ECG Devices
12.2.1.2. Stress ECG Devices
12.2.2. Holter Monitors
12.2.3. Event Monitors
12.2.4. Implantable Loop Recorders
12.2.5. Mobile Cardiac Telemetry
12.3. Market Value Forecast, by Country/Sub-region, 2017–2031
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East & Africa
12.4. Market Attractiveness Analysis
12.4.1. By Type
12.4.2. By Country/Sub-region
13. Competition Landscape
13.1. Market Share Analysis, by Company, 2020
13.2. Company Profiles
13.2.1. Abbott
13.2.1.1. Company Overview
13.2.1.2. Company Financials
13.2.1.3. Growth Strategies
13.2.1.4. SWOT Analysis
13.2.2. Boston Scientific Corporation
13.2.2.1. Company Overview
13.2.2.2. Company Financials
13.2.2.3. Growth Strategies
13.2.2.4. SWOT Analysis
13.2.3. GE Healthcare
13.2.3.1. Company Overview
13.2.3.2. Company Financials
13.2.3.3. Growth Strategies
13.2.3.4. SWOT Analysis
13.2.4. Hill-Rom Holdings
13.2.4.1. Company Overview
13.2.4.2. Company Financials
13.2.4.3. Growth Strategies
13.2.4.4. SWOT Analysis
13.2.5. Koninklijke Philips N.V.
13.2.5.1. Company Overview
13.2.5.2. Company Financials
13.2.5.3. Growth Strategies
13.2.5.4. SWOT Analysis
13.2.6. Medtronic
13.2.6.1. Company Overview
13.2.6.2. Company Financials
13.2.6.3. Growth Strategies
13.2.6.4. SWOT Analysis
13.2.7. Nihon Kohden Corporation
13.2.7.1. Company Overview
13.2.7.2. Company Financials
13.2.7.3. Growth Strategies
13.2.7.4. SWOT Analysis
13.2.8. Asahi Kasei Medical Co., Ltd.
13.2.8.1. Company Overview
13.2.8.2. Company Financials
13.2.8.3. Growth Strategies
13.2.8.4. SWOT Analysis
List of Tables
Table 01: Global Stroke Incident Cases
Table 02: Global Prevalence of Heart Failure (2017)
Table 03: Status of Cardiac Surgeries in Countries in South Asia 2016–2017
Table 04: Status of Cardiac Surgeries in North America
Table 05: New Zealand all cardiac surgery patients in 2016: age and gender
Table 06: Europe Hospital discharge rates for in-patients with diseases of the cardiovascular system, 2016-2017
Table 07: Key Product/Brand Analysis of Implantable Loop Recorder
Table 08: Key Product/Brand Analysis of Holter Monitors
Table 09: Key Product/Brand Analysis of ECG
Table 10: Key Product/Brand Analysis of Event Monitors
Table 11: Key Product/Brand Analysis of Event Monitors
Table 12: Key Product/Brand Analysis of Mobile Cardiac Telemetry
Table 13: Ambulatory Cardiac Monitoring Devices Procedures performed till 2018
Table 14: Ambulatory Cardiac Monitoring Devices Procedures performed after January 2019
Table 15: Global Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 16: Global Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
Table 17: Global Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 18: North America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 19: North America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 20: North America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
Table 21: Europe Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Europe Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 23: Europe Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
Table 24: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 25: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 26: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
Table 27: Latin America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 28: Latin America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 29: Latin America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
Table 30: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 31: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 32: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
Table 33: GE Healthcare Business Overview
Table 34: Koninklijke Philips N.V. Business Overview
Table 35: Medtronic plc Business Overview
Table 36: Abbott Laboratories Business Overview
Table 37: Boston Scientific Corporation Business Overview
Table 38: Hill-Rom Holdings, Inc. Business Overview
Table 39: Nihon Kohden Corporation Business Overview
Table 40: Asahi Kasei Medical Co., Ltd. Business Overview
List of Figures
Figure 01: Global Ambulatory Cardiac Monitoring Devices Market Share, by Type
Figure 02: Global Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
Figure 03: Procedures performed in 2017 (New Zealand)
Figure 04: Procedures performed in 2017 (Australia)
Figure 05: Value Chain Analysis
Figure 06: Global Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
Figure 07: Global Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031
Figure 08: Global Ambulatory Cardiac Monitoring Devices Market Analysis, by Region
Figure 09: Global Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Region, 2020 and 2031
Figure 10: Global Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Region, 2021–2031
Figure 11: North America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 12: North America Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Country, 2020 and 2031
Figure 13: North America Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Country, 2021–2031
Figure 14: North America Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031
Figure 15: North America Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
Figure 16: Europe Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 17: Europe Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 18: Europe Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 19: Europe Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031
Figure 20: Europe Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
Figure 21: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 22: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 23: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 24: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031
Figure 25: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
Figure 26: Latin America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 27: Latin America Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 28: Latin America Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 29: Latin America Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031
Figure 30: Latin America Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
Figure 31: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 32: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 33: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 34: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031
Figure 35: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
Figure 36: GE Healthcare Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 37: GE Healthcare Breakdown of Net Sales (%), by Region/Country, 2019
Figure 38: GE Healthcare Breakdown of Net Sales (%), by Business Segment, 2019
Figure 39: GE Healthcare R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 40: Koninklijke Philips N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 41: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Region/Country, 2019
Figure 42: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Business Segment, 2019
Figure 43: Koninklijke Philips N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 44: Medtronic plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 45: Medtronic plc Breakdown of Net Sales (%), by Region/Country, 2020
Figure 46: Medtronic plc Breakdown of Net Sales (%), by Business Segment, 2020
Figure 47: Medtronic plc R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 48: Abbott Laboratories Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 49: Abbott Laboratories Breakdown of Net Sales (%), by Region/Country, 2019
Figure 50: Abbott Laboratories Breakdown of Net Sales (%), by Business Segment, 2019
Figure 51: Abbott Laboratories R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 52: Boston Scientific Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 53: Boston Scientific Corporation Breakdown of Net Sales (%), by Region/Country, 2019
Figure 54: Boston Scientific Corporation Breakdown of Net Sales (%), by Business Segment, 2019
Figure 55: Boston Scientific Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 56: Hill-Rom Holdings, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 57: Hill-Rom Holdings, Inc. Breakdown of Net Sales (%), by Region/Country, 2020
Figure 58: Hill-Rom Holdings, Inc. Breakdown of Net Sales (%), by Business Segment, 2020
Figure 59: Hill-Rom Holdings, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 60: Nihon Kohden Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 61: Nihon Kohden Corporation Breakdown of Net Sales (%), by Region/Country, 2019
Figure 62: Nihon Kohden Corporation Breakdown of Net Sales (%), by Business Segment, 2019
Figure 63: Nihon Kohden Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 64: Asahi Kasei Medical Co., Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 65: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales (%), by Region/Country, 2019
Figure 66: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales (%), by Business Segment, 2019
Figure 67: Asahi Kasei Medical Co., Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Ambulatory Cardiac Monitoring Devices Market
